publication venue for
- Pharmacokinetics and Pharmacodynamics of Etripamil, an Intranasally Administered, Fast-Acting, Nondihydropyridine Calcium Channel Blocker. 2024
- Bioequivalence and Relative Bioavailability Studies to Assess a New Acalabrutinib Formulation That Enables Coadministration With Proton-Pump Inhibitors.. 11. 2022
- Theranos Experience Exposes Weaknesses in FDA Regulatory Discretion.. 6. 2017